Trade Mark Journal No.2026/046 13 November 2026

UK00004469548 3 November 2026 (5)

NexisQuant

Class 5: Recombinant alternatives; recombinant alternatives for in vitro diagnostics; immunoassay reagents for medical use; diagnostic reagents for medical use; immunoassay reagents for in vitro diagnostics; in vitro diagnostic tests and preparations for medical use; reagents for in-vitro laboratory use (for medical purposes); medical diagnostic reagents and assays for testing of body fluids; antibodies; human antibodies (recombinantly produced); antibodies for in-vitro diagnostic testing; recombinantly produced human rheumatoid factor antibodies; recombinantly produced human anti-thyroid peroxidase antibodies; reagents for medical use; medical diagnostic reagents; clinical medical reagents; clinical diagnostic reagents; clinical diagnostic reagents; chemical test reagents [medical]; raw reagents for medical diagnostic purposes; raw reagents for in vitro use; in vitro diagnostic preparations for medical use; diagnostic substances for medical use; diagnostic agents for medical use; diagnostic preparations for medical purposes; diagnostic preparations and materials for medical purposes; diagnostic preparations for medical purposes for use in medical laboratories.

BBI Solutions OEM Limited

Representative: HGF Limited